- Company/Commercial (189)
- Banking / Finance (101)
- Funds (49)
- Financial services (45)
- Tax (44)
- Litigation / Dispute Resolution (37)
- Real Estate (37)
- Information Technology (32)
- Intellectual Property (29)
- Private Equity (27)
- Energy (25)
- Employment (23)
- Regulatory and compliance (22)
- Insolvency & restructuring (21)
- PPP/PFI/Commercial projects (18)
- Media/Entertainment/Sport (14)
- Insurance/reinsurance (13)
- Pharma/Biotech (13)
- Healthcare (12)
- Crime (9)
- Transport (Including aviation and shipping) (9)
- Commodities (8)
- Construction (8)
- Environment (7)
- Licensing/Gaming/Betting (6)
- Telecoms (6)
- Competition/EU (5)
- Charities (3)
- Agriculture (2)
- Family (2)
- Human Rights (2)
- Pensions (2)
- Planning (2)
- Business Tax (1)
- Immigration (1)
- In-House (1)
- Other (1)
- Private Client (1)
- Professional Indemnity/Negligence (1)
- Public Sector/Local Authority (1)
- Travel and Tourism (1)
Sort By: Newest first | Oldest first
DLA Piper has been appointed as principal external legal adviser to Heineken UK in a first for the UK brewing and pub giant.
DLA Piper has made several office and regional leadership appointments in the US.
DLA Piper has advised on the largest LIC IPO on the Australian Securities Exchange since late 2006.
DLA Piper’s Mark Radcliffe, a Silicon Valley-based partner, has been chosen as one of 25 recipients of The Recorder’s first-ever ‘Innovator Award’.
DLA Piper has advised Market Tech Holdings, a holding company with iconic real-estate assets in London’s Camden Town, on its £750m AIM IPO.
DLA Piper’s role encompassed a full due diligence review of the target group, advice on the auction process and subsequent completion of the acquisition.
For this IPO, the law firm acted for Guotai Junan International, the sole sponsor and sole global co-ordinator.
DLA Piper has represented Regent Properties in its fundraising of $300m in equity commitments.
DLA Piper has advised Pfizer on the $635m (£405m) acquisition of commercial vaccines from Baxter.
DLA Piper has advised AlM-listed Seeing Machines on the Australian component of its most recent fundraising initiative.
DLA Piper has announced that the firm has been recognised in Law360’s global practice group rankings as a law firm with the largest practice group in eight specific areas of the law.
DLA Piper has acted for China’s largest pharmaceutical company on the issuance of HK$5.5bn of new shares.
Eagul Faigen and Tim Mathers will join the firm on 2 February 2015.
DLA Piper has advised EMMVEE Solar Systems on the sale of Solarpark Bronkow Luckaitztal to regional energy provider RheinEnergie.
The placing agreement was signed on 30 November 2014, pursuant to which Morgan Stanley will place an aggregate of 594,056,000 new H shares.
DLA Piper has been appointed to Royal Mail’s legal panel as part of its first comprehensive panel review since its listing on the London Stock Exchange in October 2013.
DLA Piper has represented iSocket, an advertising technology platform, in its acquisition by The Rubicon Project, an advertising automation company.
DLA Piper advised Neothetics in the pricing of its initial public offering of 4,650,000 shares of its common stock at a public offering price of $14 per share.
DLA Piper has earned a perfect score for the seventh consecutive year on the Human Rights Campaign’s 2015 Corporate Equality Index.
DLA Piper has been jointly appointed to the panel of Green Africa Power alongside Stephenson Harwood.